CBLC Antikörper (AA 244-474)
Kurzübersicht für CBLC Antikörper (AA 244-474) (ABIN2717154)
Target
Alle CBLC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 244-474
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Human recombinant protein fragment corresponding to amino acids 244-474 of human CBLC(NP_036248) produced in E.coli.
-
Isotyp
- IgG2b
-
-
anti-Cbl proto-oncogene C (CBLC) (AA 245-474) antibody
CBLC Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cbl proto-oncogene C (CBLC) (AA 245-474) antibodyCBLC Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cbl proto-oncogene C (CBLC) (AA 424-453), (C-Term) antibodyCBLC Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB0696 unconjugated
anti-Cbl proto-oncogene C (CBLC) (AA 1-30), (N-Term) antibodyCBLC Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB0694 unconjugated
anti-Cbl proto-oncogene C (CBLC) (AA 1-474) antibodyCBLC Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3F10 unconjugated
anti-Cbl proto-oncogene C (CBLC) (AA 244-474) antibodyCBLC Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 3B4 unconjugated
anti-Cbl proto-oncogene C (CBLC) (C-Term) antibodyCBLC Reaktivität: Human WB, ELISA, IHC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Cbl proto-oncogene C (CBLC) (AA 1-474) antibodyCBLC Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cbl proto-oncogene C (CBLC) (AA 244-474) antibodyCBLC Reaktivität: Human WB Wirt: Maus Monoclonal 3D9 unconjugated
anti-Cbl proto-oncogene C (CBLC) antibodyCBLC Reaktivität: Human WB, IF, IC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB 1:500, FLOW 1:100,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
-
- CBLC (Cbl proto-oncogene C (CBLC))
-
Andere Bezeichnung
- CBLC
-
Molekulargewicht
- 52.3 kDa
-
NCBI Accession
- NM_012116
-
HGNC
- 23624
-
Pathways
- EGFR Signaling Pathway
Target
-
